Equities
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.62
  • Today's Change-0.02 / -3.13%
  • Shares traded1.39m
  • 1 Year change-59.48%
  • Beta1.1665
Data delayed at least 15 minutes, as of May 31 2024 09:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

VIVA Biotech Holdings is a China-based investment holding company. The Company is principally engaged in the provision of the structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development. The Company’s core technologies include structure-based drug discovery (SBDD) platform, fragment-based drug discovery (FBDD) platform, affinity selection mass spectrometry (ASMS) screening platform and membrane protein targeted drug discovery platform. The Company operates its businesses mainly in the United States, China, Europe and other regions.

  • Revenue in HKD (TTM)2.33bn
  • Net income in HKD-125.51m
  • Incorporated2008
  • Employees2.08k
  • Location
    VIVA Biotech Holdings735 Ziping RoadZhoupu Town, Pudong New DistrictShanghai 201318ChinaCHN
  • Phone+86 2 160893288
  • Fax+86 2 158243936
  • Websitehttps://www.vivabiotech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
JW (Cayman) Therapeutics Co Ltd187.93m-830.17m965.95m398.00--0.5279--5.14-2.02-2.020.45674.410.07041.6865.54472,190.20-31.11-39.77-35.21-44.0050.74---441.74-1,316.813.86-47.820.1592--19.32--9.23---19.87--
Sunho Biologics Inc-100.00bn-100.00bn1.11bn-------------------------------------------------------155.25------
Hbm Holdings Ltd699.66m178.21m1.12bn177.006.021.145.241.600.24240.24240.95331.280.38863.903.013,952,904.009.88-54.6114.13-66.0497.7397.8125.43-400.283.286.980.3556--120.13127.06116.61---12.62--
Jacobson Pharma Corporation Ltd1.68bn212.16m1.18bn1.59k5.300.49472.980.70120.11120.14090.88221.190.37222.877.50940,829.505.164.916.616.6042.0541.8113.8514.321.015.620.364635.9711.912.8941.304.42-6.226.39
Ascletis Pharma Inc61.18m-156.43m1.23bn219.00--0.4984--20.03-0.147-0.1470.0572.430.0222.303.86279,352.10-5.62-6.43-5.91-6.6445.9235.67-255.70-243.3816.54-6.090.0036--4.63-19.3954.04---20.44--
Jacobio Pharmaceuticals Group Co Ltd68.66m-388.19m1.24bn301.00--1.06--17.99-0.5022-0.50220.08881.470.0419--5.21228,115.30-23.66-45.76-26.86-49.305.04---565.36-372.22----0.1636---33.66--3.43--19.18--
VIVA Biotech Holdings2.33bn-125.51m1.34bn2.08k--0.333111.130.5751-0.0638-0.06381.201.860.28054.845.211,121,857.00-1.30-1.39-1.79-1.6834.2634.81-4.63-5.441.151.000.3412---9.4259.3178.03--31.98--
Mabpharm Ltd94.22m-226.31m1.42bn347.00--6.42--15.10-0.0549-0.05490.02290.05380.08930.11766.02271,520.80-21.44-21.42-28.92-27.4986.32---240.19-486.400.7596-19.030.5591--55.87--0.694---26.85--
Wuhan YZY Biopharma Co Ltd0.00-207.22m1.44bn123.00--10.47-----1.12-1.120.000.7118------0.00----------------1.41-100.120.4138-------1.50------
Essex Bio-Technology Ltd1.71bn275.26m1.46bn1.48k5.500.76124.370.8580.46890.46892.873.390.61612.283.351,152,300.009.9411.2013.2114.7390.2086.0116.1319.771.46--0.132616.1629.517.7222.113.567.297.39
CStone Pharmaceuticals501.40m-396.97m1.49bn230.00--3.02--2.97-0.3147-0.31470.3970.38450.28112.443.722,179,981.00-22.25-54.76-48.85-81.6865.60---79.17-301.621.44--0.4431---3.64--59.32--52.42--
Cryofocus Medtech Shanghai Co Ltd44.27m-105.38m1.53bn392.00--8.75--34.52-0.4407-0.44070.18510.73------112,921.90--------75.83---258.23--4.08--0.0597--50.83--13.13------
Hua Medicine82.81m-228.34m1.57bn177.00--13.36--18.99-0.2336-0.23360.08480.11150.05381.6913.03467,867.20-14.84-25.61-17.56-28.8148.78---275.73-1,654.706.06--0.6238--335.31---3.80--14.07--
Immunotech Biopharm Ltd0.00-361.93m1.60bn211.00--8.53-----0.7033-0.70330.000.36470.00----0.00-38.88-37.42-50.88-45.48--------1.03-2.510.4327-------5.25---8.46--
TOT Biopharm International Co Ltd843.83m-40.81m1.68bn551.00--2.26318.421.99-0.0563-0.05631.160.96050.58081.878.031,531,452.00-2.81-20.01-3.72-25.2173.5374.74-4.84-68.531.48-4.600.3348--76.5481.8824.36--21.04--
Dawnrays Pharmaceutical (Holdings) Ltd1.24bn352.39m1.79bn1.14k5.080.57863.941.430.23440.23440.82812.060.31562.316.371,088,665.008.859.8911.3612.4954.6056.6928.0327.892.2628.890.040535.33-9.903.94-8.951.4163.922.00
Data as of May 31 2024. Currency figures normalised to VIVA Biotech Holdings's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

1.20%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 09 May 202410.29m0.48%
Bosera Asset Management Co., Ltd.as of 31 Dec 20228.30m0.38%
Norges Bank Investment Managementas of 31 Dec 20233.26m0.15%
American Century Investment Management, Inc.as of 09 May 20241.42m0.07%
Dimensional Fund Advisors Ltd.as of 31 Mar 2024929.46k0.04%
SSgA Funds Management, Inc.as of 09 May 2024886.00k0.04%
Schroder Investment Management North America, Inc.as of 28 Feb 2021442.50k0.02%
China Universal Asset Management Co., Ltd.as of 31 Dec 2023155.50k0.01%
Macquarie Investment Management Global Ltd.as of 30 Apr 2023120.00k0.01%
First Seafront Fund Management Co., Ltd.as of 31 Dec 2023105.50k0.01%
More ▼
Data from 31 Dec 2023 - 30 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.